Myomo, Inc. (NYSEAMERICAN:MYO) Stock Holdings Trimmed by AIGH Capital Management LLC

AIGH Capital Management LLC lessened its holdings in Myomo, Inc. (NYSEAMERICAN:MYO - Free Report) by 14.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,906,689 shares of the company's stock after selling 474,878 shares during the quarter. Myomo accounts for approximately 5.8% of AIGH Capital Management LLC's investment portfolio, making the stock its 2nd biggest position. AIGH Capital Management LLC owned about 9.61% of Myomo worth $13,981,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. BNP Paribas Financial Markets acquired a new position in Myomo in the fourth quarter valued at about $64,000. Walleye Capital LLC acquired a new position in Myomo during the fourth quarter worth about $66,000. Squarepoint Ops LLC acquired a new position in Myomo during the fourth quarter worth about $74,000. Schonfeld Strategic Advisors LLC acquired a new position in Myomo during the fourth quarter worth about $95,000. Finally, Jefferies Financial Group Inc. acquired a new position in Myomo during the fourth quarter worth about $101,000. Institutional investors own 44.99% of the company's stock.

Myomo Stock Performance

Shares of MYO traded down $0.04 during trading hours on Friday, reaching $2.13. 87,781 shares of the company's stock traded hands, compared to its average volume of 520,023. The firm's 50 day simple moving average is $2.57. The company has a market capitalization of $76.46 million, a PE ratio of -14.17 and a beta of 1.39. Myomo, Inc. has a 12 month low of $1.85 and a 12 month high of $7.17.

Insider Buying and Selling

In related news, CEO Paul R. Gudonis acquired 30,000 shares of the stock in a transaction on Thursday, May 15th. The stock was purchased at an average price of $3.22 per share, for a total transaction of $96,600.00. Following the completion of the transaction, the chief executive officer owned 1,051,671 shares of the company's stock, valued at $3,386,380.62. This trade represents a 2.94% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Thomas F. Kirk acquired 36,824 shares of the stock in a transaction on Thursday, May 15th. The stock was bought at an average price of $3.25 per share, with a total value of $119,678.00. Following the transaction, the director directly owned 344,700 shares of the company's stock, valued at approximately $1,120,275. The trade was a 11.96% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 118,767 shares of company stock valued at $390,093 in the last 90 days. 4.79% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on MYO. Craig Hallum set a $8.00 target price on shares of Myomo and gave the company a "buy" rating in a research report on Monday, June 23rd. Ascendiant Capital Markets increased their target price on Myomo from $11.00 to $11.50 and gave the stock a "buy" rating in a report on Thursday, June 5th. Finally, Alliance Global Partners reiterated a "buy" rating on shares of Myomo in a report on Thursday, June 26th.

Myomo Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.